Correlation Between Sartorius Stedim and Fiducial Office

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sartorius Stedim and Fiducial Office at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sartorius Stedim and Fiducial Office into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sartorius Stedim Biotech and Fiducial Office Solutions, you can compare the effects of market volatilities on Sartorius Stedim and Fiducial Office and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sartorius Stedim with a short position of Fiducial Office. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sartorius Stedim and Fiducial Office.

Diversification Opportunities for Sartorius Stedim and Fiducial Office

0.11
  Correlation Coefficient

Average diversification

The 3 months correlation between Sartorius and Fiducial is 0.11. Overlapping area represents the amount of risk that can be diversified away by holding Sartorius Stedim Biotech and Fiducial Office Solutions in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fiducial Office Solutions and Sartorius Stedim is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sartorius Stedim Biotech are associated (or correlated) with Fiducial Office. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fiducial Office Solutions has no effect on the direction of Sartorius Stedim i.e., Sartorius Stedim and Fiducial Office go up and down completely randomly.

Pair Corralation between Sartorius Stedim and Fiducial Office

Assuming the 90 days trading horizon Sartorius Stedim Biotech is expected to generate 12.33 times more return on investment than Fiducial Office. However, Sartorius Stedim is 12.33 times more volatile than Fiducial Office Solutions. It trades about 0.04 of its potential returns per unit of risk. Fiducial Office Solutions is currently generating about 0.04 per unit of risk. If you would invest  18,240  in Sartorius Stedim Biotech on September 15, 2024 and sell it today you would earn a total of  1,170  from holding Sartorius Stedim Biotech or generate 6.41% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Sartorius Stedim Biotech  vs.  Fiducial Office Solutions

 Performance 
       Timeline  
Sartorius Stedim Biotech 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Sartorius Stedim Biotech are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak primary indicators, Sartorius Stedim may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Fiducial Office Solutions 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Fiducial Office Solutions are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Fiducial Office is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Sartorius Stedim and Fiducial Office Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sartorius Stedim and Fiducial Office

The main advantage of trading using opposite Sartorius Stedim and Fiducial Office positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sartorius Stedim position performs unexpectedly, Fiducial Office can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fiducial Office will offset losses from the drop in Fiducial Office's long position.
The idea behind Sartorius Stedim Biotech and Fiducial Office Solutions pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Other Complementary Tools

Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities